Meta-analyses using event frequencies showed that corticosteroid initiation was not different between GLP1-RA and control groups among patients with IBD (OR: 0.69, 95% CI: 0.25-1.93, I2 = 99%, P = 0.48) (Figure 4). This evidence concerns the gene GLP1R and inflammatory bowel disease.